Jason R Krawic

5PUBLICATIONS
20CO-AUTHORS
Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 06, 2025
Mutations outside the MR1 antigen binding groove differentially inhibit presentation of exogenous antigens.

Corinna A Kulicke, Chance Lemon, Jason R Krawic

|Feb 24, 2024
Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation.

Corinna A Kulicke, Gwendolyn M Swarbrick, Nicole A Ladd

|Jan 26, 2024
Multiple Isomers of Photolumazine V Bind MR1 and Differentially Activate MAIT Cells.

Jason R Krawic, Nicole A Ladd, Meghan Cansler

|Oct 17, 2022
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors.

Ashley R Hoover, Saghar Kaabinejadian, Jason R Krawic

|Jul 09, 2022
Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing.

Ashley R Hoover, Kaili Liu, Christa I DeVette

Pageof 1

Frequent Collaborators

3 joint publications

Corinna A Kulicke

2 joint publications

Ashley R Hoover

2 joint publications

Aneta Worley

2 joint publications

Gwendolyn Swarbrick